China Pharma Holdings, Inc. (CPHI)
0.6411
-0.01
(-1.82%)
USD |
NYAM |
Oct 06, 16:00
0.6735
+0.03
(+5.05%)
After-Hours: 20:00
China Pharma Holdings Enterprise Value : 29.58M for Oct. 6, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 06, 2026 | 29.58M |
| October 05, 2026 | 30.06M |
| October 02, 2026 | 30.22M |
| October 01, 2026 | 30.06M |
| September 30, 2026 | 30.22M |
| September 29, 2026 | 29.95M |
| September 28, 2026 | 32.57M |
| September 25, 2026 | 34.06M |
| September 24, 2026 | 33.58M |
| September 23, 2026 | 32.78M |
| September 22, 2026 | 30.75M |
| September 21, 2026 | 31.22M |
| September 18, 2026 | 32.37M |
| September 17, 2026 | 32.41M |
| September 16, 2026 | 33.04M |
| September 15, 2026 | 33.21M |
| September 14, 2026 | 35.15M |
| September 11, 2026 | 34.41M |
| September 10, 2026 | 34.52M |
| September 09, 2026 | 35.17M |
| September 08, 2026 | 37.68M |
| September 04, 2026 | 36.83M |
| September 03, 2026 | 37.64M |
| September 02, 2026 | 37.84M |
| September 01, 2026 | 39.47M |
| Date | Value |
|---|---|
| August 31, 2026 | 39.48M |
| August 28, 2026 | 40.24M |
| August 27, 2026 | 39.51M |
| August 26, 2026 | 40.03M |
| August 25, 2026 | 39.02M |
| August 24, 2026 | 42.10M |
| August 21, 2026 | 43.31M |
| August 20, 2026 | 46.55M |
| August 19, 2026 | 47.36M |
| August 18, 2026 | 47.36M |
| August 17, 2026 | 47.36M |
| August 14, 2026 | 49.39M |
| August 13, 2026 | 47.77M |
| August 12, 2026 | 50.20M |
| August 11, 2026 | 49.39M |
| August 10, 2026 | 48.98M |
| August 07, 2026 | 49.39M |
| August 06, 2026 | 52.63M |
| August 05, 2026 | 54.66M |
| August 04, 2026 | 51.42M |
| August 03, 2026 | 49.80M |
| July 31, 2026 | 48.58M |
| July 30, 2026 | 56.28M |
| July 29, 2026 | 52.23M |
| July 28, 2026 | 56.28M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
Enterprise Value Related Metrics
| Net Income (Quarterly) | -1.458M |
| Revenue (Quarterly) | 0.9483M |
| Total Expenses (Quarterly) | 2.406M |
| EPS Diluted (Quarterly) | -0.036 |
| Gross Profit Margin (Quarterly) | -91.53% |
| Profit Margin (Quarterly) | -153.8% |
| Earnings Yield | -66.28% |
| Normalized Earnings Yield | -66.28 |